DoP rejects Glenmark's appeal on price cap of Clotrimazole Cream Farhat Nasim3 Nov 2024 12:45 PM ISTNew Delhi: The Department of Pharmaceuticals has upheld the National Pharmaceutical Pricing Authority's (NPPA) decision on the price cap for...
Pfizer Wysolone DT price challenge denied: DoP upholds NPPA ceiling on Prednisolone Tablets Farhat Nasim2 Nov 2024 1:00 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP) has upheld a price ceiling order issued by the National Pharmaceutical Pricing Authority (NPPA) on...
DoP orders NPPA to reassess price of Cipla's Advent, Synclar and Azee drugs Farhat Nasim30 Oct 2024 6:14 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP), under the Ministry of Chemicals & Fertilizers, has issued orders to the National...
DoP orders NPPA to re-evaluate ceiling price of vitamin product Thiamin 100 mg Farhat Nasim18 Oct 2024 5:53 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP) has instructed the National Pharmaceutical Pricing Authority (NPPA) to re-examine and recalculate...
Abbott's review plea challenging NPPA ceiling price fixation of 18 formulations rejected by DoP Farhat Nasim16 Oct 2024 4:59 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP) has dismissed two review applications filed by Abbott Healthcare Private Limited (AHPL) challenging...
Prices of drugs going off patent to be reduced by 50 percent Farhat Nasim15 May 2023 7:01 PM ISTNew Delhi: The Union Government has decided to slash the ceiling price of the drugs going off patent by 50 percent, and specified that the drug...
DoP rejects Intas Pharma submission against NPPA over Globucel M ceiling price Farhat Nasim28 Dec 2022 6:00 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP) has rejected Intas Pharmaceuticals' plea against the National Pharmaceutical Pricing Authority...
HC upholds 30 percent cap on trade margin of 42 anti-cancer drugs Farhat Nasim6 Dec 2022 10:30 AM ISTNew Delhi: Observing that if policy to make cancer medicine affordable is not promulgated, majority of the country's population will be vulnerable to...
No bar on taking corrective measures if error occurs in fixing retail price of drugs: NPPA Farhat Nasim28 Nov 2022 6:00 PM ISTNew Delhi: There can be no bar on National Pharmaceutical Pricing Authority (NPPA) to take corrective measures if it finds out some inconsistency or...
DoP Directs NPPA to consider Cipla application for retail price fixation of asthma drug combination Farhat Nasim5 Nov 2022 6:00 PM ISTNew Delhi: In a major respite to Cipla Ltd., embroiled in a legal battle for almost three years over the price of an Asthma inhaler drug, the...
NPPA revises retail price of Emcure Pharma Darunavir, Ritonavir FDC Farhat Nasim3 Nov 2022 6:00 PM ISTNew Delhi: The National Pharmaceuticals Pricing Authority (NPPA) has revised the retail price of Emcure Pharmaceuticals Ltd's cocktail formulation of...
Kerala HC directs Health Ministry, DoP to reply on unaffordability of patented cancer drug Ribociclib Roshni Dhar4 Oct 2022 4:49 PM ISTThe Kerala High Court has directed the Department of Pharmaceuticals (DoP) and a competent officer of Union Health Ministry to file their reply on the...
